Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Al18F-PSMA-617 vs 68Ga-PSMA-617 in Prostate Cancer
NCT05841992Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Al18F-PSMA-617 in prostate cancer (PCa), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
Al18F-PSMA-617
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05841992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05841992.